Therapeutic Drug Monitoring
TDM is defined as the use of drug levels, pharmacokinetic principles and pharmacodynamic factors to optimise drug therapy in individual patients.
1. Main Objectives :
To optimise drug therapy / improve drug efficacy
3. Achievement
Year |
No. of samples |
No. of assays done |
1993 | 863 | 920 |
1994 | 1768 | 1986 |
1995 | 1298 | 1463 |
1996 | 1363 | 1524 |
1997 | 742 | 874 |
1998 | 1266 | 1396 |
1999 | 1416 | 1521 |
2000 | 1449 | 1660 |
2001 | 1864 | 2175 |
2002 | 1661 | 1800 |
QAP Indicator:
Proportion of assays interpreted & recommendations communicated to the requesting limit / Dr to the total no. of assays received within the same working day. (Standard not less than 75%). For 2002, our achievement was 93.06%.
4. Plans for 2003
4.1 No. of assays : min. of 1600
4.2 To start
Cyclosporin monitoring.